Rapport Therapeutics Statistics

Total Valuation

RAPP has a market cap or net worth of $660.94 million. The enterprise value is $341.93 million.

Market Cap	660.94M
Enterprise Value	341.93M

Important Dates

The next estimated earnings date is Monday, February 10, 2025, before market open.

Earnings Date	Feb 10, 2025
Ex-Dividend Date	n/a

Share Statistics

RAPP has 36.58 million shares outstanding. The number of shares has increased by 1,491.15% in one year.

Current Share Class	36.58M
Shares Outstanding	36.58M
Shares Change (YoY)	+1,491.15%
Shares Change (QoQ)	+226.78%
Owned by Insiders (%)	6.78%
Owned by Institutions (%)	50.94%
Float	14.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.05
P/TBV Ratio	2.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 45.91, with a Debt / Equity ratio of 0.01.

Current Ratio	45.91
Quick Ratio	45.17
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.24M
Employee Count	58
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, RAPP has paid $6,000 in taxes.

Income Tax	6,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	22.97
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.71
Average Volume (20 Days)	150,537

Short Selling Information

The latest short interest is 1.79 million, so 4.90% of the outstanding shares have been sold short.

Short Interest	1.79M
Short Previous Month	1.74M
Short % of Shares Out	4.90%
Short % of Float	12.07%
Short Ratio (days to cover)	11.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-74.33M
Pretax Income	n/a
Net Income	-71.85M
EBITDA	-73.70M
EBIT	-74.33M
Earnings Per Share (EPS)	-$5.81

Full Income Statement

Balance Sheet

The company has $320.66 million in cash and $1.65 million in debt, giving a net cash position of $319.01 million or $8.72 per share.

Cash & Cash Equivalents	320.66M
Total Debt	1.65M
Net Cash	319.01M
Net Cash Per Share	$8.72
Equity (Book Value)	323.11M
Book Value Per Share	8.83
Working Capital	318.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$60.74 million and capital expenditures -$3.62 million, giving a free cash flow of -$64.36 million.

Operating Cash Flow	-60.74M
Capital Expenditures	-3.62M
Free Cash Flow	-64.36M
FCF Per Share	-$1.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,491.15%
Shareholder Yield	-1,491.15%
Earnings Yield	-10.87%
FCF Yield	-9.74%

Analyst Forecast

The average price target for RAPP is $37.33, which is 106.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.33
Price Target Difference	106.59%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2